results: dc enhanced pre-exercise antioxidant status (p = 0.003) and reduced by trend (p = 0.088) 1 h post-exercise plasma free [f₂-isoprostane] compared with cc (also, [f₂-isoprostane] increased post-exercise in cc and bl but not dc trials).